Status:
COMPLETED
Dual-task Training for Function in MCI
Lead Sponsor:
State University of New York at Buffalo
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and severe dementia associated with Alzheimer's disease (AD). In the United States about...
Detailed Description
Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and severe dementia associated with Alzheimer's disease (AD). In the United States about...
Eligibility Criteria
Inclusion
- 65 years of age or older
- Male or female
- Mild (23 - 26 points) cognitive impairment as screened by the Montreal Cognitive Assessment
- Having no absolute contraindications to non-physician supervised exercise as guided by the American College of Sports Medicine and Centers for Disease Control and Prevention.
Exclusion
- Having any condition that prevents safe participation in non-physician supervised exercise as screened using the Physical Activity Readiness Questionnaire for Older Adults
- Blood pressure \>180 mmHg systolic or 100 mmHg diastolic at baseline
- Presence of severe illness or disability
- Lower body amputation
- Cognitive Impairment beyond mild level, preventing provision of informed consent.
Key Trial Info
Start Date :
April 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04059705
Start Date
April 4 2023
End Date
September 17 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Buffalo-Niagara YMCA
Buffalo, New York, United States, 14223